Bio-Path Holdings
Utility Patents

Last updated:

List of all Bio-Path Holdings patents 3 in total

Status Patent
Grant
Utility: P-ethoxy nucleic acids for STAT3 inhibition External link
Filling date: 12 Sep 2025 Issue date: 22 Jun 2021
Grant
Utility: Combination therapy with liposomal antisense oligonucleotides External link
Filling date: 12 Sep 2025 Issue date: 23 Feb 2021
Grant
Utility: P-ethoxy nucleic acids for liposomal formulation External link
Filling date: 12 Sep 2025 Issue date: 26 Jan 2021

Showing 1 to 3 of 3 patents.